US healthcare company and dividend aristocrat Abbott Laboratories (ABT) announced its quarterly earnings of $0.65 per share, beating the estimated $0.58 per share. Net sales rose 2.5% to $7.73 billion, above the average estimate of $7.34 billion. Abbott Laboratories has suspended its 2020 guidance but maintained its quarterly dividend as the corona pandemic has an…
Dividend aristocrat Abbott Laboratories (ABT) reports 7.1% revenue growth and 17% growth in adjusted earnings-per-share; announces better-than-expected guidance for Q1. ABBOTT Posts strong 2019 results ABT stock rose Wednesday after the medical technology company beat fourth-quarter revenue expectations and issued strong 2020 sales guidance. The stock ended up +2.13 (+2.37%), trading at $91.86. The Q4-figure…
The Dividend Aristocrats are a select group of currently 57 S&P 500 stocks with 25+ years of consecutive dividend increases. These 57 are large, US companies that have historically provided (slightly) better performance and (slightly) lower volatility than the S&P 500 as a whole. S&P 500 applies the following criteria to construct the Dividend Aristocrats…